Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Insights and Forecast to 2027

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type
1.4.2 5-HT3 Inhibitors
1.4.3 NK1 Inhibitors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Application
1.3.2 Highly Emetogenic Chemotherapy
1.3.3 Moderately Emetogenic Chemotherapy
1.3.4 Low Emetogenic Chemotherapy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Regions by Sales
2.4.1 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Regions by Sales (2022-2027)
2.5 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Regions by Revenue
2.5.1 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers
3.1.1 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in 2020
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers
3.2.1 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue in 2020
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type
4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2016-2027)
4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type
4.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type
4.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2016-2021)
4.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application
5.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2016-2027)
5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application
5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application
5.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2016-2021)
5.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Application (2022-2027)
6 North America
6.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
6.1.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2027)
6.1.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2027)
6.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
6.2.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2027)
6.2.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2027)
6.3 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country
6.3.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2027)
6.3.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
7.1.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2017-2027)
7.1.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2017-2027)
7.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
7.2.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2017-2027)
7.2.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2017-2027)
7.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country
7.3.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2017-2027)
7.3.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
8.1.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
8.2.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region
8.3.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
9.1.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2019-2027)
9.1.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2019-2027)
9.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
9.2.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2019-2027)
9.2.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2019-2027)
9.3 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country
9.3.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2019-2027)
9.3.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
6.1.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
6.2.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country
6.3.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.1.5 Merck Related Developments
11.2 Eisai
11.2.1 Eisai Corporation Information
11.2.2 Eisai Overview
11.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.2.5 Eisai Related Developments
11.3 Mundipharma
11.3.1 Mundipharma Corporation Information
11.3.2 Mundipharma Overview
11.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.3.5 Mundipharma Related Developments
11.4 Qilu Pharma
11.4.1 Qilu Pharma Corporation Information
11.4.2 Qilu Pharma Overview
11.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.4.5 Qilu Pharma Related Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.5.5 Teva Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.6.5 Novartis Related Developments
11.7 Heron Therapeutics
11.7.1 Heron Therapeutics Corporation Information
11.7.2 Heron Therapeutics Overview
11.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.7.5 Heron Therapeutics Related Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.8.5 Roche Related Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Overview
11.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.9.5 Mylan Related Developments
11.10 Tesaro
11.10.1 Tesaro Corporation Information
11.10.2 Tesaro Overview
11.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.10.5 Tesaro Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Description
11.1.5 Merck Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain Analysis
12.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Mode & Process
12.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Marketing
12.4.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Channels
12.4.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
12.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
13.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
13.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
13.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
14 Key Findings in The Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 5-HT3 Inhibitors
Table 3. Major Manufacturers of NK1 Inhibitors
Table 4. Major Manufacturers of Other
Table 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2016-2021) & (K Units)
Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 9. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2016-2021) & (K Units)
Table 10. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2022-2027)
Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Table 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2022-2027)
Table 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturers 2016-2021 (USD/Unit)
Table 20. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs as of 2020)
Table 22. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
Table 24. Date of Manufacturers Enter into Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2016-2021)
Table 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Type (2022-2027)
Table 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2016-2021)
Table 33. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Type (2022-2027)
Table 34. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2016-2021) & (USD/Unit)
Table 35. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 37. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 38. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Application (2016-2021)
Table 39. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Application (2022-2027)
Table 40. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Application (2016-2021)
Table 43. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Application (2022-2027)
Table 44. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2016-2021) & (USD/Unit)
Table 45. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Forecast by Application (2022-2027) & (USD/Unit)
Table 46. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 47. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 48. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 51. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 52. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 55. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2022-2027) & (K Units)
Table 56. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 59. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 60. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 63. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 64. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 67. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2022-2027) & (K Units)
Table 68. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 106. Merck Corporation Information
Table 107. Merck Description and Major Businesses
Table 108. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 109. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 110. Merck Recent Developments
Table 111. Eisai Corporation Information
Table 112. Eisai Description and Major Businesses
Table 113. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 115. Eisai Recent Developments
Table 116. Mundipharma Corporation Information
Table 117. Mundipharma Description and Major Businesses
Table 118. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 120. Mundipharma Recent Developments
Table 121. Qilu Pharma Corporation Information
Table 122. Qilu Pharma Description and Major Businesses
Table 123. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 125. Qilu Pharma Recent Developments
Table 126. Teva Corporation Information
Table 127. Teva Description and Major Businesses
Table 128. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 130. Teva Recent Developments
Table 131. Novartis Corporation Information
Table 132. Novartis Description and Major Businesses
Table 133. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 134. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 135. Novartis Recent Developments
Table 136. Heron Therapeutics Corporation Information
Table 137. Heron Therapeutics Description and Major Businesses
Table 138. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 139. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
Table 140. Heron Therapeutics Recent Developments
Table 141. Roche Corporation Information
Table 142. Roche Description and Major Businesses
Table 143. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 144. Roche Chemotherapy Induced Nausea and Vomiting (CINV)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs